1. Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action

   • Angela C. Bradshaw
   • J. Georges
   • Alzheimer Europe Board

   Special Article Open access 10 February 2024 Pages: 265 - 273

2. Ethical Considerations at the Intersection of Social Media and Dementia Prevention Research

   • V. Hrincu
   • G. Zaleski
   • J. M. Robillard

   Original Research 08 January 2024 Pages: 274 - 284

   

3. Alzheimer’s Disease Biomarker Decision-Making among Patients with Mild Cognitive Impairment and Their Care Partners

   • Chelsea G. Cox
   • C. R. Salazar
   • J. D. Grill

   Original Research 08 January 2024 Pages: 285 - 293

   

4. A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants

   • C. M. Erickson
   • J. Karlawish
   • Emily A. Largent

   Brief Communication 06 February 2024 Pages: 294 - 302

   

5. Health Economic Considerations in the Deployment of an Alzheimer’s Prevention Therapy

   • Soeren Mattke
   • H. Jun
   • E. M. Reiman

   Original Research Open access 30 January 2024 Pages: 303 - 309

   

6. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Estimates from Real-World Data

   • J. Chandler
   • N. Done
   • Alzheimer’s Disease Neuroimaging Initiative

   Original Research 30 January 2024 Pages: 310 - 319

   

7. Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Findings from a Longitudinal Cohort Analysis

   • J. Chandler
   • M. Georgieva
   • T. Schilling

   Original Research 30 January 2024 Pages: 320 - 328

   

8. Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project

   • K. Malzbender
   • P. Barbarino
   • AD-RIDDLE Consortium

   Special Article Open access 30 January 2024 Pages: 329 - 338

   

9. Exploring the Association between Amyloid-β and Memory Markers for Alzheimer’s Disease in Cognitively Unimpaired Older Adults

   • Mario A. Parra
   • Y. Gazes
   • Y. Stern

   Original Research Open access 15 January 2024 Pages: 339 - 347

   

10. Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men – Secondary Analysis of the AgeWell.de-trial

    • Felix G. Wittmann
    • A. Pabst
    • S. G. Riedel-Heller

    Original Research Open access 15 January 2024 Pages: 348 - 355

11. Roles of Baseline Intrinsic Capacity and its Subdomains on the Overall Efficacy of Multidomain Intervention in Promoting Healthy Aging among Community-Dwelling Older Adults: Analysis from a Nationwide Cluster-Randomized Controlled Trial

    • C.-K. Liang
    • W.-J. Lee
    • Liang-Kung Chen

    Original Research 23 January 2024 Pages: 356 - 365

    

12. A Phase 1 Single-Ascending-Dose Trial in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravenous PNT001, a Novel Mid-domain Tau Antibody Targeting cis-pT231 Tau

    • Wendy Luca
    • K. Foster
    • M. Jefson

    Original Research Open access 24 January 2024 Pages: 366 - 374

    

13. Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study

    • Alessandro Padovani
    • S. Caratozzolo
    • A. Pilotto

    Original Research Open access 30 January 2024 Pages: 375 - 381

    

14. A Cholecystokinin Analogue Ameliorates Cognitive Deficits and Regulates Mitochondrial Dynamics via the AMPK/Drp1 Pathway in APP/PS1 Mice

    • L. Hao
    • M. Shi
    • Zijuan Zhang

    Original Research 08 January 2024 Pages: 382 - 401

    

15. Cost-Effectiveness of Prevention for People at Risk for Dementia: A Scoping Review and Qualitative Synthesis

    • Alexander Braun
    • M. Höfler
    • S. Auer

    Review Open access 15 January 2024 Pages: 402 - 413

    

16. Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer’s Disease

    • A. C. Macedo
    • D. F. P. A. Durço
    • Pedro Rosa-Neto

    Review 15 January 2024 Pages: 414 - 421

    

17. Cytomegalovirus Infection and Alzheimer’s Disease: A Meta-Analysis

    • Q. Ji
    • W. Lian
    • Yiqiang Zhan

    Review 04 October 2023 Pages: 422 - 427

    

18. Nanolithium, a New Treatment Approach to Alzheimer’s Disease: A Review of Existing Evidence and Clinical Perspectives

    • Solene Guilliot
    • E. N. Wilson
    • M. E. Soto

    Review 24 January 2024 Pages: 428 - 434

    

19. Personalized Computational Causal Modeling of the Alzheimer Disease Biomarker Cascade

    • Jeffrey R. Petrella
    • J. Jiang
    • Alzheimer’s Disease Neuroimaging Initiative

    Original Research 08 January 2024 Pages: 435 - 444

    

20. Fruit Intake and Alzheimer’s Disease: Results from Mendelian Randomization

    • Wan-Zhe Liao
    • X.-F. Zhu
    • Xu-Guang Guo

    Brief Communication 31 January 2024 Pages: 445 - 452

    

21. Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions

    • G. García-Lluch
    • Juan Pardo Albiach
    • Consuelo Cháfer-Pericás

    Original Research 15 January 2024 Pages: 453 - 462

    

22. The MAPP Room Memory Test: Examining Contextual Memory Using a Novel Computerized Test in Cognitively-Unimpaired Individuals with Autosomal Dominant Alzheimer’s Disease

    • A. Giudicessi
    • P. A. Aduen
    • Yakeel T. Quiroz

    Brief Communication 08 January 2024 Pages: 463 - 468

    

23. Beyond Vision: A View from Eye to Alzheimer’s Disease and Dementia

    • C. Zheng
    • R. Zeng
    • Honghua Yu

    Review Open access 15 September 2023 Pages: 469 - 483

    

24. Higher Cognitive Reserve Is Beneficial for Cognitive Performance Via Various Locus Coeruleus Functional Pathways in the Pre-Dementia Stage of Alzheimer’s Disease

    • Liang Gong
    • K. Chen
    • Alzheimer’s Disease Neuroimaging Initiative

    Original Research 04 October 2023 Pages: 484 - 494

    

25. Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer’s Disease

    • F. Yang
    • N. Zhang
    • Shu-wen Xu

    Original Research 08 January 2024 Pages: 495 - 506

    

26. The Impact of Testosterone on Alzheimer’s Disease Are Mediated by Lipid Metabolism and Obesity: A Mendelian Randomization Study

    • L. Zhang
    • F. Yang
    • Lin Yang

    Original Research 14 September 2023 Pages: 507 - 513

    

27. Unsupervised Online Paired Associates Learning Task from the Cambridge Neuropsychological Test Automated Battery (CANTAB®) in the Brain Health Registry

    • Miriam T. Ashford
    • A. Aaronson
    • R. L. Nosheny

    Original Research Open access 25 September 2023 Pages: 514 - 524

    

28. Alzheimer’s Disease-Associated APOE ε4 Frequencies in Indian Population Genomes May Suggest Implications in Lecanemab Treatment

    • B. Jolly
    • Vinod Scaria

    Letter to the Editor 25 September 2023 Pages: 525 - 526

    

29. Chronic Pain in Multiple Sites and Dementia: A Vicious Cycle?

    • J. Tian
    • G. Jones
    • Feng Pan

    Letter to the Editor 17 September 2023 Pages: 527 - 528